Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 28 record(s)

Req # A-2022-00047

Copies of the draft Detailed Project Description, draft Application Information Requirements, draft Initial Project Description, draft Engagement Plan, draft Project Description Summary pertaining to what is now known as the "Ksi Lisims LNG" project. The requester is aware of certain documents that are available publicly via the Canadian Impact Assessment Registry (the "Registry") and requests only those documents which have not already been made available via the Registry. In so far as they are available, digital copies of documents are preferred. The requester also requests only copies of French documents where English documents are not provided.

Organization: Impact Assessment Agency of Canada

0 page(s)
July 2023

Req # A-2023-00001

All records regarding Indigenous Services Canada and Employment and Social Development Canada's involvement with the Northern Road Link Project, generated between Jan. 1, 2020 and April 19, 2023, in .PDF form. This includes any documents and correspondence prepared by the entities for the Impact Assessment Agency of Canada with regards to the Northern Road Link project. This also includes the public comments Indigenous Services Canada prepared for the Impact Assessment Agency of Canada for the planning phase of the Impact Assessment for the Northern Link road. Impact assessment project reference #84331, comment reference #29. This also includes the public comments Employment and Social Development Canada prepared for the Impact Assessment Agency of Canada for the planning phase of the Impact Assessment for the Northern Link road. Impact assessment project reference #84331, comment reference #24

Organization: Impact Assessment Agency of Canada

80 page(s)
July 2023

Req # A-2023-00004

Copy of the briefing note for the Regional Assessment in the Ring of Fire Area Letters to Indigenous Leaders. Received: Feb 13, 2023. Sector: Operations. Proactive disclosure Reference Number: 20069445.

Organization: Impact Assessment Agency of Canada

65 page(s)
July 2023

Req # A-2023-00005

Provide the 2022, 2023 (calendar year) documentation that lead the Minister requesting impact assessments be done. Include exchanges, documentation exchanged between the minister and officials. Provide 2022, 2023 (calendar year) documentation on the positives and negative effects of regional assessments where used or proposed to be used, including for the ring of fire project. Calendar year = January 1, 2022 to December 31, 2022 and January 1, 2023 to June 26, 2023

Organization: Impact Assessment Agency of Canada

0 page(s)
July 2023

Req # A-2022-05111

Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.

Organization: Patented Medicine Prices Review Board Canada

197 page(s)
July 2023

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023

Req # A-2023-025600

For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
July 2023

Req # A-2020-00052

ONLY FINAL VERSIONS:Information (including but not limited to correspondence, briefing notes, and emails) relating to: (1) Indigenous cooperation and jurisdiction regulations under the Impact Assessment Act; (2) The impact assessment process for the Gazoduq pipeline in the context of Indigenous cooperation and jurisdiction regulations; and (3) The recognition of "jurisdiction" under section 114(1)(e) of the Impact Assessment Act. We also request information specific to the following meetings: - Meeting Kebaowek First Nation and Impact Assessment Agency of Canada that occurred on February 17, 2021; and - Meeting with Kebaowek First Nation and Impact Assessment Agency of Canada that occurred on October 7, 2020. Date range for all: August 2019 to March 18, 2021

Organization: Impact Assessment Agency of Canada

5265 page(s)
July 2022
Date modified: